Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-69,874
Closed -$3.83M 72
2025
Q2
$3.83M Buy
69,874
+275
+0.4% +$15.4K 1.52% 25
2025
Q1
$3.94M Buy
69,599
+125
+0.2% +$7.04K 2.03% 17
2024
Q4
$3.99M Sell
69,474
-1,715
-2% -$97.7K 1.62% 23
2024
Q3
$3.73M Sell
71,189
-3,200
-4% -$166K 1.62% 22
2024
Q2
$4.03M Sell
74,389
-1,200
-2% -$65.5K 1.66% 23
2024
Q1
$4.38M Buy
75,589
+2,384
+3% +$123K 1.93% 22
2023
Q4
$3.59M Buy
+73,205
New +$3.46M 1.99% 25

Other funds holding CPRT

Geneva Partners's CPRT Position: Q3 2025 in Review

Geneva Partners sold out of Copart (CPRT) in Q3 2025, closing a stake of 69,874 shares — an estimated $3.83M sold.

Geneva Partners first reported a position in CPRT in Q4 2023 and held it in 7 quarters. The position peaked at $4.38M in Q1 2024. 1,146 funds tracked by Wall St. Rank hold CPRT as of Q3 2025.

  • Geneva Partners reported no remaining Copart position as of Q3 2025 after selling out during the quarter.
  • Geneva Partners sold 69,874 Copart shares in Q3 2025, an estimated $3.83M.
  • Geneva Partners first reported a position in Copart in Q4 2023 and held it in 7 quarters.
  • Geneva Partners's Copart position peaked at $4.38M in Q1 2024.
  • 1,146 funds tracked by Wall St. Rank held Copart as of Q3 2025.

Based on Geneva Partners's 13F filing for Q3 2025, filed 12 Nov 2025.